Company · CIK 0001649989 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Outlook Therapeutics, Inc. · OTLK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 PForm 4 → | Aug 14, 8:57 pm EDT | Robert Charles JahrChief Executive Officer, Director | 151,515 | — | — | 151,515 | — | |
| Aug 14, 2026 PForm 4 → | Aug 14, 7:39 pm EDT | Lawrence A KenyonChief Financial Officer, Director | 101,010 | — | — | 106,956 | — | |
| Aug 12, 2026 PForm 4 → | Aug 14, 7:52 pm EDT | Ghiath M. Sukhtian +1Director, 10% Owner | 2,525,252 | $0.99 | $2,499,999 | 24,617,320 | +11.4% | |
| Jul 29, 2026 PForm 4 → | Jul 29, 3:19 pm EDT | Faisal Ghiath SukhtianDirector | 95,398 | $1.05 | $99,996 | 220,972 | +76.0% | |
| Jun 2, 2026 PForm 4 → | Jun 3, 6:03 pm EDT | Yezan Munther HaddadinDirector | 29,000 | $0.8326 | $24,145 | 66,167 | +78.0% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 2, 4:32 pm EDT | Kevin Michael LundquistChief Financial Officer | 500,000 | — | — | 500,000 | — | |
| Aug 14, 2026 PForm 4 → | Aug 14, 8:57 pm EDT | Robert Charles JahrChief Executive Officer, Director | 151,515 | — | — | 151,515 | — | |
| Aug 14, 2026 PForm 4 → | Aug 14, 7:39 pm EDT | Lawrence A KenyonChief Financial Officer, Director | 101,010 | — | — | 101,010 | — | |
| Aug 12, 2026 PForm 4 → | Aug 14, 7:52 pm EDT | Ghiath M. Sukhtian +1Director, 10% Owner | 2,525,252 | — | — | 2,525,252 | — | |
| Jul 21, 2026 AForm 4 → | Jul 23, 7:49 pm EDT | Lawrence A KenyonChief Financial Officer, Director | 210,078 | — | — | 210,078 | — | |
| Jul 21, 2026 AForm 4 → | Jul 23, 7:34 pm EDT | Robert Charles JahrChief Executive Officer, Director | 100,000 | — | — | 100,000 | — |